title: News in multiple sclerosis: Remyelination as a therapeutic target.
authors.affiliation: Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, Universidad Complutense, Instituto de Investigación Sanitaria San Carlos (idiSSC), Madrid, España. Electronic address: inc.hcsc@salud.madrid.org.
authors.forename: Jorge
authors.initials: J
authors.lastname: Matías-Guiu
authors.affiliation: Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, Universidad Complutense, Instituto de Investigación Sanitaria San Carlos (idiSSC), Madrid, España.
authors.forename: Ulises
authors.initials: U
authors.lastname: Gomez-Pinedo
authors.affiliation: Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, Universidad Complutense, Instituto de Investigación Sanitaria San Carlos (idiSSC), Madrid, España.
authors.forename: Jordi A
authors.initials: JA
authors.lastname: Matias-Guiu
mesh_terms: D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D018373:Peripheral Nervous System Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000074586:Remyelination / Q000187:drug effects*
chemical_list: D007155:Immunologic Factors; D018373:Peripheral Nervous System Agents